Here are five things to know:
1. The five-week trial culminated in a favorable outcome for the surgeon, with a 10 to two jury vote.
2. The jury found the spine surgeon did not perform below the standard of medical care when he performed the 2007 spine surgery.
3. The spine surgeon used the Norian bone cement. Synthes bought the California-based company Norian, and transformed one of its bone-cement products for spine use.
4. The plaintiff also sued Synthes and four company executives, but the company settled during the trial’s fourth week.
5. The patient died on the operating table allegedly due to massive blood clots.
More articles on spine:
Women report inferior outcomes in lumbar spinal fusions: 5 key notes
Do you know what patients really care about when choosing a spine surgeon?
4 observations of relationship between pedicle screw fixation strength & bone material density
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.